IL6 and cancer: The present data demonstrated that therapeutic dosages of aspirin counteract the down-regulation of p53 expression and the major EMT changes, i.e. the reduction in E-cadherin expression and increased cell invasiveness [51, 52], which are induced by IL-6 stimulation in cancer and non-cancerous cell lines.